OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
ITPRIPL1 binds CD3ε to impede T cell activation and enable tumor immune evasion
Shouyan Deng, Yibo Zhang, Huanbin Wang, et al.
Cell (2024) Vol. 187, Iss. 9, pp. 2305-2323.e33
Closed Access | Times Cited: 15
Shouyan Deng, Yibo Zhang, Huanbin Wang, et al.
Cell (2024) Vol. 187, Iss. 9, pp. 2305-2323.e33
Closed Access | Times Cited: 15
Showing 15 citing articles:
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition
Antonino Glaviano, Hannah Lau, Lukas M. Carter, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 5
Antonino Glaviano, Hannah Lau, Lukas M. Carter, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 5
Chitosan-based hydrogels in cancer therapy: Drug and gene delivery, stimuli-responsive carriers, phototherapy and immunotherapy
Hailin Zhu, Haowei Sun, Jingyuan Dai, et al.
International Journal of Biological Macromolecules (2024) Vol. 282, pp. 137047-137047
Closed Access | Times Cited: 4
Hailin Zhu, Haowei Sun, Jingyuan Dai, et al.
International Journal of Biological Macromolecules (2024) Vol. 282, pp. 137047-137047
Closed Access | Times Cited: 4
Post-translational modifications in hepatocellular carcinoma: unlocking new frontiers in immunotherapy
Yuexian Piao, Naicui Zhai, Xiaoling Zhang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Yuexian Piao, Naicui Zhai, Xiaoling Zhang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Growth Inhibitory Peptides: A Potential Novel Therapeutic Approach to Cancer Treatment
Aixin Wang, Gerald J. Mizejewski, Chengqi Zhang
European Journal of Pharmacology (2025), pp. 177554-177554
Closed Access
Aixin Wang, Gerald J. Mizejewski, Chengqi Zhang
European Journal of Pharmacology (2025), pp. 177554-177554
Closed Access
Circ_0001947 encapsulated by small extracellular vesicles promotes gastric cancer progression and anti-PD-1 resistance by modulating CD8+ T cell exhaustion
Bingyu Wang, Wenbo Liu, Mingming Zhang, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Bingyu Wang, Wenbo Liu, Mingming Zhang, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Yizhen Chen, Yuanyuan Zheng, Shaolin Liu
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 20
Open Access | Times Cited: 2
Causal Effects and Immune Cell Mediators of Prescription Analgesic Use and Risk of Liver Cancer and Precancerosis in European Population: A Mendelian Randomization Study
Xuewen Tao, Shuai Mao, Jincheng Wang, et al.
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1537-1537
Open Access | Times Cited: 1
Xuewen Tao, Shuai Mao, Jincheng Wang, et al.
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1537-1537
Open Access | Times Cited: 1
Focusing on CD8+ T-cell phenotypes: improving solid tumor therapy
Zhouchi Yao, Yayun Zeng, Cheng Liu, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 1
Zhouchi Yao, Yayun Zeng, Cheng Liu, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 1
Allosteric antibodies: a novel paradigm in drug discovery
Léxane Fournier, Enrico Guarnera, Harald Kolmar, et al.
Trends in Pharmacological Sciences (2024)
Open Access | Times Cited: 1
Léxane Fournier, Enrico Guarnera, Harald Kolmar, et al.
Trends in Pharmacological Sciences (2024)
Open Access | Times Cited: 1
A comprehensive pan-cancer analysis revealing the role of ITPRIPL1 as a prognostic and immunological biomarker
Wenyuan Duan, Wenhao Tian, Zhongyi Li, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access
Wenyuan Duan, Wenhao Tian, Zhongyi Li, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access
Association between programmed death protein 1-related single-nucleotide polymorphisms and immune-related adverse events induced by programmed death protein 1 inhibitors—a pilot study
Linxuan Cai, Ziyan Lyu, Yuan Zhang, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113269-113269
Closed Access
Linxuan Cai, Ziyan Lyu, Yuan Zhang, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113269-113269
Closed Access
TM9SF1 expression correlates with autoimmune disease activity and regulates antibody production through mTOR-dependent autophagy
Juan Xiao, Zhen-Wang Zhao, Fengqiao Zhou, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access
Juan Xiao, Zhen-Wang Zhao, Fengqiao Zhou, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access
Lipid metabolism-related gene signature predicts prognosis and unveils novel anti-tumor drugs in specific type of diffuse large B cell lymphoma
Cancan Wang, Ran Zhang, Huan Zhang, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access
Cancan Wang, Ran Zhang, Huan Zhang, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access
Innovative strategies to optimise colorectal cancer immunotherapy through molecular mechanism insights
Quanjun Lin, Zhiqiang Wang, Jue Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Quanjun Lin, Zhiqiang Wang, Jue Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Soluble TREM2 drives triple-negative breast cancer progression via activation of the AKT pathway
Peng Yin, Yuehua Jiang, Xiaoyun Ji, et al.
International Immunopharmacology (2024) Vol. 145, pp. 113750-113750
Closed Access
Peng Yin, Yuehua Jiang, Xiaoyun Ji, et al.
International Immunopharmacology (2024) Vol. 145, pp. 113750-113750
Closed Access
